AI English summary of an SEC filing — figures as filed
AMETEK said 2024 net sales were $6,941.2 million, an increase of $344.2 million or 5.2%, and net income was $1,376.1 million, with diluted earnings per share of $5.93. The company said the net sales increase was due to a 7% increase from acquisitions, partially offset by a 2% organic sales decline.
Key points
AI summaryAMETEK said 2024 net sales were $6,941.2 million, an increase of $344.2 million or 5.2%, and net income was $1,376.1 million, with diluted earnings per share of $5.93. The company said the net sales increase was due to a 7% increase from acquisitions, partially offset by a 2% organic sales decline.
AMETEK said 2024 EIG net sales were $4,659.9 million, an increase of 0.8%, with operating margins of 30.7% compared with 28.3% in 2023, and EMG net sales were $2,281.3 million, an increase of 15.6%, with operating margins of 20.0% compared with 25.2% in 2023.
AMETEK said 2024 cash provided by operating activities was $1,828.8 million and free cash flow was $1,701.7 million. Total debt, net at the end of 2024 was $2,079.7 million, lower than $3,313.3 million at the end of 2023, and the company said it paid in full, at maturity, 3.73% senior notes of $300 million in Q3.
AMETEK said it repurchased approximately 1.2 million shares for $212.0 million in 2024 and paid dividends of $258.8 million. The company also said its Board of Directors approved an increase in the quarterly dividend to $0.31 effective February 7, 2025 and approved a $1.25 billion share repurchase authorization.
Key figures
Fiscal year ended December 31, 2024
- Revenue
- $6.9B
- Operating income
- $1.8B
- Net income
- $1.4B
- EPS
- $5.93
- Operating cash flow
- $1.8B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
2024 net sales, net income and diluted earnings per share increase
AMETEK said 2024 net sales were $6,941.2 million, an increase of $344.2 million or 5.2%, and net income was $1,376.1 million, with diluted earnings per share of $5.93. The company said the net sales increase was due to a 7% increase from acquisitions, partially offset by a 2% organic sales decline.
Source · Based on the MD&A text of the filing
Segment net sales and operating margins differ
AMETEK said 2024 EIG net sales were $4,659.9 million, an increase of 0.8%, with operating margins of 30.7% compared with 28.3% in 2023, and EMG net sales were $2,281.3 million, an increase of 15.6%, with operating margins of 20.0% compared with 25.2% in 2023.
Source · Based on the MD&A text of the filing
Operating cash flow and total debt, net decline
AMETEK said 2024 cash provided by operating activities was $1,828.8 million and free cash flow was $1,701.7 million. Total debt, net at the end of 2024 was $2,079.7 million, lower than $3,313.3 million at the end of 2023, and the company said it paid in full, at maturity, 3.73% senior notes of $300 million in Q3.
Source · Based on the MD&A text of the filing
Share repurchases, dividends and 2025 subsequent events
AMETEK said it repurchased approximately 1.2 million shares for $212.0 million in 2024 and paid dividends of $258.8 million. The company also said its Board of Directors approved an increase in the quarterly dividend to $0.31 effective February 7, 2025 and approved a $1.25 billion share repurchase authorization.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…